These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 26446354)
41. Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor. Cocco E; Varughese J; Buza N; Bellone S; Lin KY; Bellone M; Todeschini P; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Carrara L; Tassi R; Pecorelli S; Lockwood CJ; Santin AD Clin Exp Metastasis; 2011 Oct; 28(7):689-700. PubMed ID: 21725665 [TBL] [Abstract][Full Text] [Related]
42. Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer. Uno K; Homma S; Satoh T; Nakanishi K; Abe D; Matsumoto K; Oki A; Tsunoda H; Yamaguchi I; Nagasawa T; Yoshikawa H; Aonuma K Br J Cancer; 2007 Jan; 96(2):290-5. PubMed ID: 17211468 [TBL] [Abstract][Full Text] [Related]
43. Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line. Drake TA; Ruf W; Morrissey JH; Edgington TS J Cell Biol; 1989 Jul; 109(1):389-95. PubMed ID: 2663880 [TBL] [Abstract][Full Text] [Related]
44. Quantitative PET Imaging of Tissue Factor Expression Using 18F-Labeled Active Site-Inhibited Factor VII. Nielsen CH; Erlandsson M; Jeppesen TE; Jensen MM; Kristensen LK; Madsen J; Petersen LC; Kjaer A J Nucl Med; 2016 Jan; 57(1):89-95. PubMed ID: 26383146 [TBL] [Abstract][Full Text] [Related]
45. c-Met activation in medulloblastoma induces tissue factor expression and activity: effects on cell migration. Provençal M; Labbé D; Veitch R; Boivin D; Rivard GE; Sartelet H; Robitaille Y; Gingras D; Béliveau R Carcinogenesis; 2009 Jul; 30(7):1089-96. PubMed ID: 19359592 [TBL] [Abstract][Full Text] [Related]
46. Tissue factor expression and tumor-infiltrating T lymphocytes in ovarian carcinomas and their association with venous thromboembolism. Gi T; Yamashita A; Aman M; Kuwahara A; Asada Y; Kawagoe Y; Onishi J; Sameshima H; Sato Y Pathol Int; 2021 Apr; 71(4):261-266. PubMed ID: 33559251 [TBL] [Abstract][Full Text] [Related]
47. Studies of the activation of factor VII bound to tissue factor. Rao LV; Williams T; Rapaport SI Blood; 1996 May; 87(9):3738-48. PubMed ID: 8611699 [TBL] [Abstract][Full Text] [Related]
48. Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier. Tominaga N; Kosaka N; Ono M; Katsuda T; Yoshioka Y; Tamura K; Lötvall J; Nakagama H; Ochiya T Nat Commun; 2015 Apr; 6():6716. PubMed ID: 25828099 [TBL] [Abstract][Full Text] [Related]
49. The many faces of tissue factor. Mackman N J Thromb Haemost; 2009 Jul; 7 Suppl 1(Suppl 1):136-9. PubMed ID: 19630786 [TBL] [Abstract][Full Text] [Related]
51. The fluorochrome-to-protein ratio is crucial for the flow cytometric detection of tissue factor on extracellular vesicles. Weiss R; Mostageer M; Eichhorn T; Huber S; Egger D; Spittler A; Tripisciano C; Kasper C; Weber V Sci Rep; 2024 Mar; 14(1):6419. PubMed ID: 38494537 [TBL] [Abstract][Full Text] [Related]
52. Microparticle bearing tissue factor: a link between promyelocytic cells and hypercoagulable state. Gheldof D; Mullier F; Bailly N; Devalet B; Dogné JM; Chatelain B; Chatelain C Thromb Res; 2014 Mar; 133(3):433-9. PubMed ID: 24290525 [TBL] [Abstract][Full Text] [Related]
53. [Change of tissue factor pathway ratio during attack in patients with acute myocardial infarction and its clinical significance]. Wang R; Wen BZ; Ma YT; Peng -; Li H; Zhong D; Li L Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):198-202. PubMed ID: 19236778 [TBL] [Abstract][Full Text] [Related]
54. Lipid starvation and hypoxia synergistically activate ICAM1 and multiple genes in an Sp1-dependent manner to promote the growth of ovarian cancer. Koizume S; Ito S; Nakamura Y; Yoshihara M; Furuya M; Yamada R; Miyagi E; Hirahara F; Takano Y; Miyagi Y Mol Cancer; 2015 Apr; 14():77. PubMed ID: 25879517 [TBL] [Abstract][Full Text] [Related]
55. The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis. Hoffman M; Monroe DM Dis Mon; 2003 Jan; 49(1):14-21. PubMed ID: 12525825 [TBL] [Abstract][Full Text] [Related]
56. Increasing the sensitivity of the human microvesicle tissue factor activity assay. Vallier L; Bouriche T; Bonifay A; Judicone C; Bez J; Franco C; Guervilly C; Hisada Y; Mackman N; Houston R; Poncelet P; Dignat-George F; Lacroix R Thromb Res; 2019 Oct; 182():64-74. PubMed ID: 31450010 [TBL] [Abstract][Full Text] [Related]
57. III. Instantaneous inhibition by compound 48/80 of tissue factor-initiated extrinsic coagulation is mediated by the downregulation of factor VII activation. Chu AJ; Wang ZG; Fox MJ Arch Biochem Biophys; 2000 May; 377(2):357-65. PubMed ID: 10845714 [TBL] [Abstract][Full Text] [Related]
58. Microparticles in vascular disorders: how tissue factor-exposing vesicles contribute to pathology and physiology. Kleinjan A; Böing AN; Sturk A; Nieuwland R Thromb Res; 2012 Oct; 130 Suppl 1():S71-3. PubMed ID: 23026670 [TBL] [Abstract][Full Text] [Related]
59. Heterogeneity of microvesicles from cancer cell lines under inflammatory stimulation with TNF-α. Gieseler F; Plattfaut C; Quecke T; Freund A; Ungefroren H; Ender F Cell Biol Int; 2018 Nov; 42(11):1533-1544. PubMed ID: 30080276 [TBL] [Abstract][Full Text] [Related]
60. Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events. Campo G; Valgimigli M; Ferraresi P; Malagutti P; Baroni M; Arcozzi C; Gemmati D; Percoco G; Parrinello G; Ferrari R; Bernardi F Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2800-6. PubMed ID: 17008590 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]